Executive Summary For the global B2B pharmaceutical ecosystem, the year 2025 is seen as critical for both COVID-relat...
Named-Patient Import Programs: A Global Guide for Hospitals & Procurement Teams (2026) Around the world, a large...
The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...
Quick intro Global pharma buyers generally source their generic APIs from India and China due to their vast productio...
Introduction The pharmaceutical industry in the CIS (Commonwealth of Independent States) and Eastern Europe is develo...
The CIS and Eastern Europe are gradually turning into one of the world's most important markets for multinational ph...
Introduction The Latin American pharmaceutical market is an ever-increasing sector that keeps on drawing global inves...
Introduction Southeast Asia is one of the regions in the world where the healthcare market is growing at the fastest...
Introduction: Why Revenue-Loss Drugs Matter As is the case every year, a handful of highly successful drugs lose thei...
Introduction: Why 2026 Is a Landmark Patent Cliff Year The year 2026 is going to be very significant in the curr...
Introduction: Why CDMOs are Important After Patent Expiry When the patent protection period of a product ends, the ma...
Introduction Typically, drug patent expiries drive the global pharmaceutical market. When a key item begins to lose i...
Stay updated on pharma trends and marketplace opportunities.